By Staff
Wednesday, February 12, 2025 12:21 AM
PARIS—
EssilorLuxottica (Euronext: EL) announced that it has acquired Toronto-based
Cellview Imaging Inc., a Canadian manufacturer of ophthalmic imaging devices for early-stage eye disease detection.
By Staff
Thursday, January 30, 2025 12:18 AM
NEW YORK—
AI Optics Inc., an AI-focused medical device company, announced that it has received Food and Drug Administration (FDA) 510(k) clearance for its
Sentinel Camera, a handheld retinal imaging system that captures images of the human eye.
By Staff
Tuesday, January 14, 2025 12:21 AM
DUBLIN, Calif. and JENA, Germany—Zeiss Medical Technology announced that its
MEL 90 received approval from the U.S. Food and Drug Administration (FDA), giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia and mixed astigmatism.
By Staff
Wednesday, October 16, 2024 12:18 AM
MANSFIELD, Mass.—
Hilco Vision has announced the appointment of Geoff Cochran to the role of national account director in the vision care solutions division. In this role, Cochran will develop and expand key partnerships, as well as accelerate growth opportunities and initiatives to expand the reach of Hilco Vision and its portfolio of brands.
By Staff
Tuesday, March 5, 2024 12:15 AM
LOMBARD, Ill.—
Visionix USA announced Friday that it has appointed
Insight Medical Technologies as the dedicated sales and service provider for Visionix refraction and screening platforms, Optovue OCT and OCT-A, as well as Briot and Weco finishing systems in Canada.
By Staff
Wednesday, July 6, 2022 12:24 AM
BIRMINGHAM, United Kingdom—Optical technology specialist
Eyoto Group will open its U.S. corporate headquarters in Dallas in October 2022, with Eyoto chief executive officer Paul Clapton relocating to set up and lead the U.S. operations, according to a company announcement.
By Staff
Wednesday, May 25, 2022 12:30 AM
MIDDLETOWN, Pa.—
MacuLogix Inc., a company founded a decade ago to support ECPs with the tools and resources needed to diagnose and monitor patients with age-related macular degeneration (AMD), is winding down operations and has assigned its assets to a firm that specializes in working with creditors in business liquidation processes, according to a filing in the
Delaware Court of Chancery late last week. This assignment of assets includes patent rights and related intellectual property. Maculogix, which conducted a months-long search for a buyer or new investors, owes approximately $23 million to secured creditors, according to the court filing.